HIV organisations react to NICE draft guidance not recommending use of two month-injectable PrEP
NICE, the body which produces guidelines for which treatments are available within the NHS, has published draft guidance not recommending the use of the first available long-acting injectable form of PrEP, Cabotegravir. PrEP is medication which can be taken to prevent a person from acquiring HIV. Cu